< Zurück zu den aktuellen Neuigkeiten & Events

Auszeichnungen

HGF ranked ‚Gold‘ in the Financial Times special report

Juli 2019

HGF has been ranked in ‚Gold‘ for:

  • Chemistry & pharmacy
  • Electrical engineering & physics
  • Mechanical engineering
  • Biotechnology, food & healthcare

And ‚Silver‘ for:

  • Materials & nanotechnology
  • IT & software

HGF has been ranked in the ‚Gold‘ and ‚Silver‘ bands in The Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on 9 July 2019.

The firm is one of the largest firms of IP specialists in Europe, with 21 offices across the UK, Ireland,  Germany, The Netherlands, Austria and Switzerland, and is internationally recognised by its peers across these 6 core areas of technology.

Kate Taylor – Head of the Life Sciences team commented, „I am delighted to receive this level of recognition from our clients and peer group. The team comprises some exceptional attorneys with in-depth experience from in-house roles and academia. We have a wealth of expertise across the life sciences spectrum, and of particular note is the firm’s technical and legal reputation in the area of CRISPR, led by Cath Coombes and Dr Claire Irvine.“ 

Matt Dixon – Head of the Engineering team commented, „Receiving a gold ranking is testament to the exceptional quality of the team we have built across Europe. The work we are undertaking in the fields of energy and medical devices are particularly key to the growth we have experienced.“

Dr Andrew Wells – Head of the Chemistry team commented, „The chemical team has grown significantly in the last 5 years and our client base is international and representative of all the key areas of chemistry and pharmaceuticals. We have a large number of attorneys who have in-house backgrounds and this has been a strong benefit for advising clients on IP strategies in this often-complex sector.“

The research was undertaken by The FT’s partner Statista, the market research provider, who compiled the list based on the survey results. A special report featuring the final list and articles exploring the work and role of European patent attorneys appeared in print in the Financial Times and on FT.com on July 9 2019. The survey collected peer recommendations from patent attorneys registered with the European Patent Office (EPO) as well as names from clients who have used a patent law firm in one of the 38 member states of the Munich-based EPO.

As a firm we are committed to building strong client relationships and delivering outstanding service from our offices in Germany, The Netherlands, Switzerland, Austria, Ireland and the UK we are delighted to have been ranked in Gold and Silver. HGF has a clear strategic growth plan under the leadership of Paul Sanderson, CEO.

The firm’s expansion across Europe has continued in 2019 with the merger of Patronus IP which expanded HGF offices into Munich, Heidelberg and Salzburg. This year the firm has also opened Dublin. Unlike other multi-office IP firms, HGF is one integrated firm that draws on its expertise across all offices and across all our attorney teams of: Law, Trade Marks, Electronics, Engineering, Chemistry and Life Sciences to assemble multi-disciplinary client teams that work together to meet clients’ needs.

For the full report see here.

Aktuelle Neuigkeiten

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Weiterlesen

IQPC Global US Exchange

HGF ist stolzer „Silver Plus“-Sponsor des IQPC Global US Exchange, welche vom 28. bis 29. Januar 2025 im Austin Marriot South, Texas stattfindet. HGF-Partner und Leiter der Elektronikabteilung Chris Benson …

Weiterlesen

Update zum „Precision Breeding Act 2023“: Einzelheiten zum neuen vereinfachten Regulierungsweg für genetisch veränderte pflanzliche und tierische Lebens- und Futtermittelprodukte in UK werden bekannt

Das Gesetz zur Gentechnologie (Präzisionszucht) in UK von 2023 könnte bereits im Frühjahr 2025 in Kraft treten. Es ermächtigt die Food Standards Agency (FSA), einen neuen vereinfachten Regulierungsweg für die …

Weiterlesen

Entscheidung des Berufungsgerichts bestätigt Nichtigkeit eines Patents aufgrund einer Änderung, die die Ausführungsform als außerhalb des Geltungsbereichs der Ansprüche identifiziert

In einem Fall, der die Herausforderungen hervorhebt, die sich aus Änderungen nach der Erteilung ergeben, und insbesondere die Auslegung der Ansprüche im Hinblick auf die Beschreibung, hat das Berufungsgericht in …

Weiterlesen

Das Berufungsgericht des UPC erläutert den Ansatz zur Auslegung von Ansprüchen mit „offensichtlichen“ Fehlern

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] – Berufungsgericht des UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20. Dezember 2024 Alexion Pharmaceuticals, Inc. gegen Amgen Technology (Ireland) Unlimited …

Weiterlesen

IP-Zutaten: Winter-Fallrecht-Überprüfung 2024

Wenn die Nächte hereinbrechen und die Hektik, alles vor den Feiertagen fertig zu bekommen, ihren Höhepunkt erreicht, ist es an der Zeit, eine Pause einzulegen, sich sein Lieblings-Heißgetränk und eine …

Weiterlesen